Cite
HARVARD Citation
Paller, A. et al. (2022). Dupilumab in children aged 6 months to younger than 6 years with uncontrolled atopic dermatitis: a randomised, double-blind, placebo-controlled, phase 3 trial. Lancet. 400 (10356), pp. 908-919. [Online].